U.S.

stock index futures saw a downturn on Thursday, as escalating oil prices indicated a sustained restrictive monetary policy.

The market keenly awaited economic data and Federal Reserve Chair Jerome Powell’s comments expected later the day.

Dow e-minis were down by 0.02% at 33,783, S&P 500 e-minis were down by 0.13% at 4,308 and Nasdaq 100 e-minis were down by 0.31% at 14,693.75.

Among the top three NYSE percentage premarket gainers were Leju Holdings, GameStop, and Elctriq Power Holding, while the top three premarket losers were Carmax Inc, Vicarious Surgical, and Graf Acquisition.

The top gainers on Nasdaq were Bionomics (ASX:BNO), Freedom Acquisition I Corp, and Inpixon, with Ascent Solar Technologies and Pasithea Therapeutics at the losing end.

Peloton Interactive Inc saw a premarket upswing of 12.5%, spurred by a new 5-year partnership with Lululemon.

Bionomics (ASX:BNO) also rallied, up by 225.9% premarket, as their PTSD drug found success in a mid-stage study.

GameStop Corp recorded a gain of 9.0% in premarket trading following the appointment of billionaire Ryan Cohen as CEO.

Bionomics is a biopharmaceutical company specializing in the discovery and development of novel therapeutics for the treatment of serious central nervous system disorders.